Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
103M
-
Shares change
-
+5.01M
-
Total reported value, excl. options
-
$827M
-
Value change
-
+$24.7M
-
Put/Call ratio
-
18.51
-
Number of buys
-
85
-
Number of sells
-
-64
-
Price
-
$8.01
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q2 2024
176 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q2 2024.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103M shares
of 148M outstanding shares and own 69.67% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (14.2M shares), JANUS HENDERSON GROUP PLC (13.3M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (8.03M shares), BVF INC/IL (7.57M shares), RTW INVESTMENTS, LP (7.38M shares), BlackRock Inc. (7.02M shares), VANGUARD GROUP INC (4.8M shares), Pictet Asset Management Holding SA (3.6M shares), STATE STREET CORP (3.24M shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (2.32M shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.